Moderna’s COVID-19 Vaccine To Move Faster Into Phase III
Three Veterans Recruited To Add Experience To Team
Executive Summary
mRNA company confident as it heads towards Phase II trials, but says efficacy and approval will not be a ‘binary event’.
You may also be interested in...
Pharma Leaders Confront Another Daunting Challenge: Meeting COVID-19 Demand
Pharma leaders at the CNBC Healthy Returns virtual conference said they are optimistic industry will deliver a SARS-COV-2 vaccine, but ramping up the supply will require time and collaboration.
Novartis Nominates Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.
Corbus And Janux Lead Q1’s Small-Cap Winners
Corbus has presence in both antibody drug conjugates and obesity, and was the stand-out small-cap target for investors with a fivefold increase in its share price in Q1.